Delving into the Latest Updates on Desloratadine/Prednisolone with Synapse

Overview

Basic Info

Drug Type

Small molecule drug

Synonyms-

Target

GR x H1 receptor

Action

agonists, antagonists

Mechanism

GR agonists(Glucocorticoid receptor agonists), H1 receptor antagonists(Histamine H1 receptor antagonists)

Therapeutic Areas

Immune System DiseasesInfectious DiseasesOtorhinolaryngologic Diseases+ [1]

Active Indication-

Inactive Indication

Cutaneous hypersensitivityRhinitis, Allergic

Originator Organization

EMS SA (Brazil)

Active Organization-

Inactive Organization

EMS SA (Brazil)

License Organization-

Drug Highest PhaseDiscontinuedPhase 3

First Approval Date-

Regulation-

Login to view timeline

Multicenter, randomized, parallel-group, double-blind, double-dummy, comparative clinical trial of the superiority of the fixed-dose combination of desloratadine 0.5 mg/mL and prednisolone 4 mg/mL from Eurofarma Laboratórios SA versus desloratadine 0.5 mg/mL in the treatment of moderate to severe persistent allergic rhinitis in children aged 6 to 12 years.
⚠️Study will only be conducted in research centers in Brazil (please do not send e-mail if your center is outside brazil).

Start Date08 Jul 2024

Sponsor / Collaborator

Eurofarma Laboratórios SA

NCT01529242

/ TerminatedPhase 3

A Double-blind, Randomized, Multicenter Parallel-group Study on Efficacy of Desloratadine and Prednisolone Association Compared to Dexchlorpheniramine and Betamethasone Association in Children (2-12 Years) With Acute Cutaneous Rash

The purpose of this study is to evaluate the non-inferiority clinical efficacy of two different drug associations in the treatment of acute cutaneous rash in children between 2 and 12 years old.

Start Date01 Feb 2014

Sponsor / Collaborator

EMS SA (Brazil)

NCT01720485

/ Unknown statusPhase 3

A Double-blind,Double Dummy, Randomized, Multicenter Parallel-group Study on Efficacy of Desloratadine and Prednisolone Association Compared to Dexchlorpheniramine and Betamethasone Association in Adults With Moderate - Severe Persistent Allergic Rhinitis

The purpose of this study is to evaluate the non-inferiority clinical efficacy of two different drug associations in the treatment of Moderate - Severe Persistent Allergic Rhinitis in Adults.

Start Date01 Oct 2013

Sponsor / Collaborator

EMS SA (Brazil)

100 Clinical Results associated with Desloratadine/Prednisolone

Login to view more data

100 Translational Medicine associated with Desloratadine/Prednisolone

Login to view more data

100 Patents (Medical) associated with Desloratadine/Prednisolone

Login to view more data

100 Deals associated with Desloratadine/Prednisolone

Login to view more data